BBA
TTHI

Baker Bros. Advisors’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Baker Bros. Advisors’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-769,230
Closed -$5.25M – 138
2015
Q1 		$5.25M Buy
+769,230
New +$5.31M 0.04% 74

Other funds holding TTHI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Baker Bros. Advisors's TTHI Position: Q2 2015 in Review

Baker Bros. Advisors sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q2 2015, closing a stake of 769,230 shares — an estimated $5.25M sold.

Baker Bros. Advisors first reported a position in TTHI in Q1 2015 and held it in 1 quarter. The position peaked at $5.25M in Q1 2015. 30 funds tracked by Wall St. Rank hold TTHI as of Q2 2015.

  • Baker Bros. Advisors reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q2 2015 after selling out during the quarter.
  • Baker Bros. Advisors sold 769,230 TRANSITION THERAPEUTICS INC (CANADA) shares in Q2 2015, an estimated $5.25M.
  • Baker Bros. Advisors first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q1 2015 and held it in 1 quarter.
  • Baker Bros. Advisors's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $5.25M in Q1 2015.
  • 30 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q2 2015.

Based on Baker Bros. Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.